Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

Description

Illuccix will be used per the prescribing instructions for PET-CT imaging on the United Imaging scanner uEXPLORER to establish a standard scanning protocol.

Conditions

Metastatic Castration-resistant Prostate Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

Illuccix will be used per the prescribing instructions for PET-CT imaging on the United Imaging scanner uEXPLORER to establish a standard scanning protocol.

Total Body PET-CT Imaging of Prostate Cancer Using Illuccix (Kit for the Preparation of Ga-68 PSMA-11 Injection)

Total Body PET-CT Imaging of Prostate Cancer Using Illuccix

Condition
Metastatic Castration-resistant Prostate Cancer
Intervention / Treatment

-

Contacts and Locations

Grand Rapids

BAMF Health, Grand Rapids, Michigan, United States, 49503

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Provision of signed and dated informed consent form
  • 2. Male ≥ 18 years of age
  • 3. Patients meeting clinical need for Illuccix PET scan:
  • 1. Patients with suspected metastasis who are candidates for initial definitive therapy
  • 2. Patients with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level
  • 4. Patient is physically able to lay flat for the PET-CT procedure
  • 1. Assessment by the Investigator as unable or unwilling to comply with the requirements of the protocol.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

BAMF Health,

Study Record Dates

2023-12